Effect of Binder Type and Binder Level on the Properties of Agglomerates Containing Lactose and Dibasic Calcium Phosphate Dihydrate - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Effect of Binder Type and Binder Level on the Properties of Agglomerates Containing Lactose and Dibasic Calcium Phosphate Dihydrate
The authors studied the effect of the combination of binders on the flow and compressibility characteristics of the agglomerates of binary combination of lactose and dibasic calcium phosphate dihydrate.


Pharmaceutical Technology
Volume 32, Issue 10, pp. 54-64

7. J.I. Wells, D.A. Bhatt, and K.A. Khan, "Improved Wet Massed Tableting using Plasticized Binder," J. Pharm. Pharmacol. 34 (suppl.), 46P (1982).

8. T. Abberger, "Influence of Binder Properties, Method of Addition, Powder Type and Operating Conditions on Fluid Melt Granulation and Resulting Tablet Properties," Pharmazie 56 (12), 949–952 (2001).

9. S.K. Joneja et al., "Investigating the Fundamental Effects of Binder on Pharmaceutical Tablet Performance," Drug Dev. Ind. Pharm. 25 (10), 129–135 (1999).

10. M.C. Gohel and P.D. Jogani, "Exploration of Melt Granulation Technique for the Development of Coprocessed Directly Compressible Adjuvant Containing Lactose and Microcrystalline Cellulose," Pharm. Dev. Technol. 8 (2), 143–151 (2003).

11. L. Rambali et al., "Using Experimental Design to Optimize the Process Parameters in Fluidized-Bed Granulation," Drug Dev. Ind. Pharm. 27 (1), 47–55 (2001).

12. S.I. Badway et al., "Effect of Process Parameters on Compressibility of Granulation Manufactured in a High-Shear Mixer," Int. J. Pharm. 198 (1), 51–61 (2000)

13. A. Cannon and K. Shemeley, "Statistical Evaluation of Vial Design Features that Influence Sublimation Rate during Primary Drying," Pharm. Res. 21 (3), 536–542 (2004).

14. W. Sibanda et al., "Experimental Design for the Formulation and Optimization of Novel Cross-Linked Oilispheres Developed for In Vitro Site-Specific Release of Mentha Piperita Oil," AAPS PharmSciTech. 5 (1), E18, 2004.

15. J.Z. Li et al., "The Role of Intra- and Extragranular Microcrystalline Cellulose in Tablet Dissolution," Pharm. Dev. Technol. 1 (4), 343–355 (1996).

16. A.Mckenna and D. F. McCafferty, "Effect of Particle Size on the Compaction Mechanism and Tensile Strength of Tablets," J. Pharm. Pharmacol. 34 (6), 347–351 (1982).

17. R.L. Carr, "Evaluating Flow Properties of Solids," Chem. Eng. 72, 163–168 (1965).

18. "Friability," in USP 24–NF 19 (United States Pharmacopoeial Convention, Rockville, MD, 2000), p. 2148.

19. "Disintegration Time," in USP 24–NF 19 (United States Pharmacopoeial Convention, Rockville, MD, 2000), p. 1941.

20. "Acetaminophen Tablets," in USP 24–NF 19 (United States Pharmacopoeial Convention, Rockville, MD, 2000), p. 20.

21. K.I. Chukwu and O.K. Udeala, "Binding Effectiveness of Colocassia esculenta Gum in Poorly Compressible Drugs: Acetaminophen and Metronidazole Tablet Formulation," Boll. Chim. Farm. 139 (2), 89–97 (2000).

22. S. Mattsson and C. Nystrom, "Evaluation of Critical Binder Properties Affecting the Compactibility of Binary Mixtures," Drug Dev. Ind. Pharm. 27 (3), 181–194 (2001).

23. R.L. Arellano, "Study of Load Capacity of Avicel PH-200 and Cellactose, Two Direct Compression Excipients Using Experimental Design," Drug Dev. Ind. Pharm. 26 (4), 465–469 (2000).

24. S.K. Nachaegari and A.K. Bansal, "Coprocessed Excipients for Solid Dosage Forms," Pharm. Technol. 28 (1), 32–42 (2004).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here